Sign In
Buy BRKR
$62.70
+5.39 (+9.40%)
At Close: Jun 03, 2026
Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid
12:16pm, Monday, 29'th Apr 2024
Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
07:00am, Friday, 26'th Apr 2024
BARCELONA, Spain--(BUSINESS WIRE)---- $BRKR #BRKR--At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibili
Bruker Announces Date and Time of First Quarter 2024 Earnings Release and Webcast
04:01pm, Thursday, 25'th Apr 2024
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024.
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline
11:07am, Thursday, 25'th Apr 2024
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bruker to Acquire the NanoString Business in an Asset Deal
07:00am, Monday, 22'nd Apr 2024
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., hea
Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process
09:05pm, Wednesday, 17'th Apr 2024
NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.
Bruker (BRKR) Introduces Magnet Technology for NMR Adoption
10:06am, Tuesday, 09'th Apr 2024
Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
10:51am, Friday, 22'nd Mar 2024
Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.
Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?
12:36pm, Thursday, 14'th Mar 2024
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
10:10am, Thursday, 14'th Mar 2024
Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.
Bruker (BRKR) Announces Advanced timsTOF Solutions at US HUPO
08:55am, Tuesday, 12'th Mar 2024
Bruker (BRKR) advances CCS-Enabled 4D-Proteomics timsTOF solutions for immunopeptidomes and glycoproteomics at the US HUPO 2024.
Here's Why Investors Should Retain Bruker (BRKR) Stock Now
09:26am, Tuesday, 05'th Mar 2024
The strength of the BSI BioSpin and CALID groups bodes well for Bruker (BRKR).
Bruker (BRKR) Inks Definitive Agreement to Acquire ELITechGroup
09:41am, Friday, 01'st Mar 2024
Bruker (BRKR) announces a share purchase agreement to acquire the molecular diagnostics innovator ELITechGroup.
Bruker's (BRKR) New Launches Drive Growth Amid FX Woes
11:56am, Monday, 26'th Feb 2024
Bruker's (BRKR) revenues continue to be driven by the strength of end markets, including academic and government, and industrial.
2 Instruments Stocks to Buy From a Prospering Industry
11:31am, Tuesday, 20'th Feb 2024
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the cha
